Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new Nat Commun publication citation was added to the Publications section, including the full citation and DOI. The update also removes the 'Online ahead of print' note from the previous reference and adds a 'Revision: v3.6.4' tag.
    Difference
    0.1%
    Check dated 2026-07-28T05:26:19.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page's revision history indicates a new revision tag (v3.6.3) was added with dates 2026-07-02 and 2026-06-30, and the previous revision v3.6.2 was removed (dates 2026-04-02 and 2026-03-31). These entries reflect backend/versioning updates rather than changes to visible content.
    Difference
    0.3%
    Check dated 2026-07-06T18:15:39.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2 on the page, indicating a post-release adjustment to the page template or documentation. This represents a small internal update rather than any change to the study information presented.
    Difference
    0.1%
    Check dated 2026-06-29T14:47:15.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now states recruitment is closed with a new 'No longer looking for participants' notice and adds navigation/help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). It also updates the Intervention/Treatment label formatting and includes a site revision note 'Revision: v3.6.0' (replacing 'Revision: v3.5.5').
    Difference
    0.4%
    Check dated 2026-06-15T08:24:43.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Footer branding and links were updated to reflect the sponsor and related trial site, and the page revision tag was updated from v3.5.4 to v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-08T03:50:29.000Z thumbnail image
  9. Check
    70 days ago
    Change Detected
    Summary
    Publications section was added, including a citation for a Nat Commun article and notes that publications are automatically filled from PubMed, signaling new study outputs. Several footer/branding items ('Moffitt Cancer Center Clinical Trials website', 'H. Lee Moffitt Cancer Center and Research Institute', 'Helpful Links Provided by') were removed.
    Difference
    0.4%
    Check dated 2026-06-01T02:46:13.000Z thumbnail image

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.